SLC29A2
Reaktivität: Human, Maus, Ratte
WB, IF (cc), IF (p)
Wirt: Kaninchen
Polyclonal
Alexa Fluor 350
Applikationshinweise
SLC29A2 antibody can be used for detection of SLC29A2 by Western blot at 1 - 2 μ,g/mL. Antibody can also be used for immunohistochemistry starting at 2.5 μ,g/mL. For immunofluorescence start at 20 μ,g/mL.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1 mg/mL
Buffer
SLC29A2 antibody is supplied in PBS containing 0.02 % sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
SLC29A2 antibody can be stored at 4°C for three months and -20°C, stable for up to one year.
Target
SLC29A2
(Solute Carrier Family 29 (Nucleoside Transporters), Member 2 (SLC29A2))
DER12 antikoerper, ENT2 antikoerper, HNP36 antikoerper, Der12 antikoerper, Ent2 antikoerper, Hnp36 antikoerper, ent2 antikoerper, der12 antikoerper, hnp36 antikoerper, MGC82995 antikoerper, DKFZp468L038 antikoerper, zgc:110527 antikoerper, solute carrier family 29 member 2 antikoerper, solute carrier family 29 (nucleoside transporters), member 2 antikoerper, solute carrier family 29 (equilibrative nucleoside transporter), member 2 L homeolog antikoerper, solute carrier family 29 (equilibrative nucleoside transporter), member 2 antikoerper, SLC29A2 antikoerper, Slc29a2 antikoerper, slc29a2.L antikoerper, slc29a2 antikoerper
Hintergrund
SLC29A2 is a member of the equilibrative nucleoside transporter family which plays a key role in nucleoside and nucleobase uptake for salvage pathways of nucleotide synthesis (1,2). SLC29A2 is a transmembrane glycoprotein that mediates the cellular uptake of nucleosides from the surrounding medium (3). As a nucleoside transporter, SLC29A2 plays an important role in the uptake of nucleoside-based anti-cancer drugs, polymorphisms of point mutations in the gene encoding this protein may affect the efficacy of these drugs (4).